Views & Analysis

The amount of patient data has skyrocketed, providing opportunities to gain a deeper understanding of diseases that are

Janssen on driving R&D innovation with data science

https://pharmaphorum.com/r-d/janssen-rd-innovation-data-science/

R&D/ Views & Analysis/ Views and analysis

Early diagnosis key to future Alzheimer’s treatments

mike.hammerton@pharmaphorum.com Aduhelm, Alzheimer's, Alzheimer's Research UK, Biogen, Lilly, RetiSpec 0 Comment

The approval of Biogen’s Alzheimer’s treatment could herald a new generation of therapies, but before that can happen,

Early diagnosis key to future Alzheimer’s treatments

https://pharmaphorum.com/r-d/early-diagnosis-key-to-future-alzheimers-treatments/

Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

The transformation of brain implants

Jessica Hagen biomarker, epilepsy, neurology, Neurosoft, traumatic brain injury 0 Comment

Nicolas Vachicouras, CEO of Neurosoft Bioelectronics, tells us how Neurosoft’s electrode implant aims to reduce inflammation and scar

The transformation of brain implants

https://pharmaphorum.com/r-d/the-transformation-of-brain-implants/

R&D/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

The power of R&D collaborations to improve outcomes in rare diseases

mike.hammerton@pharmaphorum.com genomic medicine, IQVIA, orphan drugs, precision medicine, Rare diseases 0 Comment

Far more common than initially thought, rare disease treatments remain far too scarce. The answer to the problem,

The power of R&D collaborations to improve outcomes in rare diseases

https://pharmaphorum.com/webinars/pharma-research-outcomes-rare-diseases/

Podcast/ R&D/ Video/ Views & Analysis/ Views and analysis

Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast

Dominic Tyer COVID-19, data, digital, manufacturing, Novartis, supply chain 0 Comment

Episode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply

Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast

https://pharmaphorum.com/r-d/novartis-amit-nastik-covid-supply-chain/

R&D/ Views & Analysis/ Views and analysis

Treatment for all: the key steps to better representation in pharma

mike.hammerton@pharmaphorum.com clinical trials, diversity, inclusion, Page & Page 0 Comment

As people have become more conscious and vocal about diversity and inclusion, Page & Page’s Lisa Lishman says

Treatment for all: the key steps to better representation in pharma

https://pharmaphorum.com/r-d/diversity-representation-pharma-clinical-trials/

R&D/ Views & Analysis/ Views and analysis

Early detection of cancers will require blood sweat and tears

mike.hammerton@pharmaphorum.com Biosignatures, cancer screening, diagnostics, Galleri, Grail, NHS, Sneeden Campbell 0 Comment

An NHS study of a new cancer blood test holds huge promise, but will not be without its

Early detection of cancers will require blood sweat and tears

https://pharmaphorum.com/r-d/galleri-test-nhs-early-detection-cancers/

R&D/ Views & Analysis/ Views and analysis

France’s biotech ecosystem is primed for growth – it’s time to feed it

mike.hammerton@pharmaphorum.com Biotech, France, Jeito Capital 0 Comment

After some years of stagnant funding and growth France is now at an inflection point for health care

France’s biotech ecosystem is primed for growth – it’s time to feed it

https://pharmaphorum.com/r-d/france-biotech-ecosystem-jeito-capital/

Kantar Health's Biotech Insights podcast with Genmab

Podcast/ R&D/ Video/ Views & Analysis/ Views and analysis

Biotech Insight podcast: Overcoming planning challenges in oncology

Dominic Tyer Biotech, Biotech Insight, forecasting, Genmab, kantar health, Oncology, planning 0 Comment

The first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges

Biotech Insight podcast: Overcoming planning challenges in oncology

https://pharmaphorum.com/r-d/biotech-insight-podcast-oncology-planning/

«‹ 7 8 9 10 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

Views & Analysis

Login